Postpartum Depression: When Should Health Care Providers Identify Those at Risk?

Michelle McKean, Aaron B. Caughey, Melanie A. Yuracko McKean, Michael D. Cabana, Valerie J. Flaherman

Research output: Contribution to journalArticle

Abstract

Maternal postpartum depression (PPD) has an impact on mothers and infants. The American Academy of Pediatrics recommends screening for PPD at well-child visits during the first 6 months. We conducted a secondary data analysis of depression screening data collected each month during months 1 to 12 postpartum for 152 mothers with an infant participating in a randomized controlled trial. We used descriptive statistics to describe the incidence and the cumulative incidence of a positive PPD screen during months 1 to 12 postpartum. The results indicate that the initial positive screen for PPD can occur any time during the first 12 months postpartum and 15% had their first positive screen between months 6 and 12. Additionally, positive PPD screens are consistently high throughout the first year postpartum with the highest rate of positive screens at 12 months postpartum (23%). Our data suggest that PPD screening through 12 months may be most beneficial for families.

Original languageEnglish (US)
Pages (from-to)689-693
Number of pages5
JournalClinical Pediatrics
Volume57
Issue number6
DOIs
StatePublished - Jun 1 2018
Externally publishedYes

Fingerprint

Postpartum Depression
Health Personnel
Postpartum Period
Mothers
Incidence
Randomized Controlled Trials
Depression
Pediatrics

Keywords

  • depression
  • duration
  • onset
  • pediatrics
  • postpartum
  • screening
  • timing

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Postpartum Depression : When Should Health Care Providers Identify Those at Risk? / McKean, Michelle; Caughey, Aaron B.; Yuracko McKean, Melanie A.; Cabana, Michael D.; Flaherman, Valerie J.

In: Clinical Pediatrics, Vol. 57, No. 6, 01.06.2018, p. 689-693.

Research output: Contribution to journalArticle

McKean, Michelle ; Caughey, Aaron B. ; Yuracko McKean, Melanie A. ; Cabana, Michael D. ; Flaherman, Valerie J. / Postpartum Depression : When Should Health Care Providers Identify Those at Risk?. In: Clinical Pediatrics. 2018 ; Vol. 57, No. 6. pp. 689-693.
@article{02e1b1fdef964d51889fcf9c7b0af1e8,
title = "Postpartum Depression: When Should Health Care Providers Identify Those at Risk?",
abstract = "Maternal postpartum depression (PPD) has an impact on mothers and infants. The American Academy of Pediatrics recommends screening for PPD at well-child visits during the first 6 months. We conducted a secondary data analysis of depression screening data collected each month during months 1 to 12 postpartum for 152 mothers with an infant participating in a randomized controlled trial. We used descriptive statistics to describe the incidence and the cumulative incidence of a positive PPD screen during months 1 to 12 postpartum. The results indicate that the initial positive screen for PPD can occur any time during the first 12 months postpartum and 15{\%} had their first positive screen between months 6 and 12. Additionally, positive PPD screens are consistently high throughout the first year postpartum with the highest rate of positive screens at 12 months postpartum (23{\%}). Our data suggest that PPD screening through 12 months may be most beneficial for families.",
keywords = "depression, duration, onset, pediatrics, postpartum, screening, timing",
author = "Michelle McKean and Caughey, {Aaron B.} and {Yuracko McKean}, {Melanie A.} and Cabana, {Michael D.} and Flaherman, {Valerie J.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1177/0009922817733696",
language = "English (US)",
volume = "57",
pages = "689--693",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Postpartum Depression

T2 - When Should Health Care Providers Identify Those at Risk?

AU - McKean, Michelle

AU - Caughey, Aaron B.

AU - Yuracko McKean, Melanie A.

AU - Cabana, Michael D.

AU - Flaherman, Valerie J.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Maternal postpartum depression (PPD) has an impact on mothers and infants. The American Academy of Pediatrics recommends screening for PPD at well-child visits during the first 6 months. We conducted a secondary data analysis of depression screening data collected each month during months 1 to 12 postpartum for 152 mothers with an infant participating in a randomized controlled trial. We used descriptive statistics to describe the incidence and the cumulative incidence of a positive PPD screen during months 1 to 12 postpartum. The results indicate that the initial positive screen for PPD can occur any time during the first 12 months postpartum and 15% had their first positive screen between months 6 and 12. Additionally, positive PPD screens are consistently high throughout the first year postpartum with the highest rate of positive screens at 12 months postpartum (23%). Our data suggest that PPD screening through 12 months may be most beneficial for families.

AB - Maternal postpartum depression (PPD) has an impact on mothers and infants. The American Academy of Pediatrics recommends screening for PPD at well-child visits during the first 6 months. We conducted a secondary data analysis of depression screening data collected each month during months 1 to 12 postpartum for 152 mothers with an infant participating in a randomized controlled trial. We used descriptive statistics to describe the incidence and the cumulative incidence of a positive PPD screen during months 1 to 12 postpartum. The results indicate that the initial positive screen for PPD can occur any time during the first 12 months postpartum and 15% had their first positive screen between months 6 and 12. Additionally, positive PPD screens are consistently high throughout the first year postpartum with the highest rate of positive screens at 12 months postpartum (23%). Our data suggest that PPD screening through 12 months may be most beneficial for families.

KW - depression

KW - duration

KW - onset

KW - pediatrics

KW - postpartum

KW - screening

KW - timing

UR - http://www.scopus.com/inward/record.url?scp=85043686053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043686053&partnerID=8YFLogxK

U2 - 10.1177/0009922817733696

DO - 10.1177/0009922817733696

M3 - Article

C2 - 28969467

AN - SCOPUS:85043686053

VL - 57

SP - 689

EP - 693

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 6

ER -